Research and Development Agreement

RESEARCH AND DEVELOPMENT DISTRIBUTION AGREEMENT FOR THE PURCHASE OF PEPTIDES

This Research and Development Agreement ("Agreement") is made and entered into by and between Power Peptide ("Distributor") and the undersigned practitioner ("Provider")

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, the parties agree as follows:

 

1. Research and Development Standards: All peptides purchased by Provider from Distributor shall be conducted under Research and Development ("R&D") standards and requirements. All peptides distributed by Power peptide are not intended to diagnose, treat, cure, or prevent disease, and that no claim or warranty is made to that effect. You further understand and agree that consumption of any of these products carries significant risk and are not FDA authorized or approved to prevent, treat, diagnose, mitigate, or cure any disease, ailment or medical condition.

2. Documentation: Power peptide shall provide all necessary documentation related to product quality including certificate of analysis.

3. Compliance with Laws and Regulations: The Provider shall comply with all applicable federal, state, and local laws and regulations relating to the purchase and use of peptides, including but not limited to, those regulations set forth by the pharmacy board in Provider's state. Power peptide shall not be responsible for unauthorized use or distribution of peptides by Provider.

4. Term and Termination: This Agreement shall remain in effect until terminated by either party upon written notice to the other party.

5. Confidentiality: The Provider agrees to maintain the confidentiality of any information provided by the distributor, including but not limited to, R&D protocols, COA's, and other documentation.

6. Indemnification: The Provider shall indemnify and hold harmless the distributor, its officers, directors, employees, and agents, from any and all claims, damages, liabilities, costs, and expenses arising out of or in connection with the Provider's purchase and use of peptides.

7. Entire Agreement: This Agreement constitutes the entire agreement between the parties and supersedes all prior negotiations, understandings, and agreements between them, whether written or oral.



The customer acknowledges the potential risks associated with handling, using, and distributing these products, and certifies that they have the appropriate equipment, facilities, and personnel to manage these risks. It is the responsibility of the provider to use these products only for their intended purposes and not for any other inappropriate applications.